Bioporto A-S Aktie

Kaufen

Verkaufen

0,1708 EUR +0,0036 EUR +2,15 %

08:14:31

FSE

1,39 DKK +0,03 DKK +1,91 %

25.07.2025

CPH

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

JETZT LOSLEGEN

Bei einem anderen Broker handeln Smartphone

Marktkap.84,43 Mio. EUR

Div. Rendite0,00%

WKN893191

ISINDK0011048619

SymbolTHOXF

Bioporto A-S Aktien News

Sortieren:Datum Meistgelesen

12.06.25GlobeNewswireGrant of Warrants

10.06.25GlobeNewswireBioPorto A/S Announces the Appointment of a New CEO as Part of its Succession Planning Strategy

08.05.25GlobeNewswireContinued progress on key strategic milestones in Q1 2025. Total revenue in line with expectations and guidance for 2025 maintained.

28.04.25GlobeNewswireGrant of Warrants

25.04.25GlobeNewswireManagers’ transactions

25.04.25GlobeNewswireBioPorto A/S raises DKK 33.5 million in new capital round - Change of number of shares and votes

15.04.25GlobeNewswirePrivate placement of 25,000,000 new shares fully subscribed – gross proceeds of DKK 33.5 million, to BioPorto A/S

14.04.25GlobeNewswireBioPorto A/S initiates a private placement of up to 25,000,000 new shares at market price. The Board of Directors has received advance indications for the full offering which is expected to raise proc

11.04.25GlobeNewswireResolutions of the Annual General Meeting

01.04.25GlobeNewswireUpdated biographies for board candidates at the upcoming Annual General Meeting

20.03.25GlobeNewswireNotice convening the Annual General Meeting in BioPorto A/S

20.03.25GlobeNewswireBioPorto announces the Annual Report for 2024

19.03.25GlobeNewswireBioPorto announces guidance for 2025 and aspirations for 2026 towards 2029

04.03.25GlobeNewswireBioPorto A/S announces Jens Due Olsen as a Board of Directors candidate intending to appoint Jens Due Olsen as Chair, along with updates on other candidates

27.02.25GlobeNewswireStrengthening of Investor Focus – BioPorto enters Market Maker Agreement with Danske Bank & appoints New Head of Investor Relations

29.01.25GlobeNewswireBioPorto A/S appoints new interim Chairman of the Board

06.01.25GlobeNewswirePreliminary Financial Figures for the 2024 Fiscal Year

16.12.24GlobeNewswireBioPorto commences process to appoint new Chair of the Board of Directors

14.11.24GlobeNewswireBioPorto Announces Interim Results and Business Update for the Third Quarter and Nine Months of Fiscal 2024

04.11.24GlobeNewswireGrant of Warrants

29.10.24GlobeNewswireFirst Patient In - BioPorto Initiates Patient Enrollment for US Study of ProNephro AKI (NGAL)™ for Adult Use at Massachusetts General Hospital

28.10.24GlobeNewswireBioPorto Enters Global Distribution Partnership with Beckman Coulter for Acute Kidney Injury NGAL Tests

15.08.24GlobeNewswireBioPorto Announces Interim Results and Business Update for the Second Quarter and Six Months of Fiscal 2024

04.07.24GlobeNewswireGrant of Warrants

24.06.24GlobeNewswireManagers’ transactions

24.06.24GlobeNewswireChanges of number of shares and votes in BioPorto A/S

18.06.24GlobeNewswirePrivate placement of 50,000,000 new shares oversubscribed - gross proceeds of DKK 81.4 million, corresponding to USD 11.7 million, to BioPorto A/S.

17.06.24GlobeNewswireBioPorto A/S initiates a private placement of 50,000,000 new shares at market price.

30.05.24GlobeNewswireBioPorto A/S Appoints Chief Financial Officer

08.05.24GlobeNewswireFirst Quarter 2024: Strong growth in US sales of The NGAL Test

30.04.24GlobeNewswireResolutions of Annual Geneal Meeting

23.04.24GlobeNewswireGrant of warrants

10.04.24GlobeNewswireBioPorto A/S Appoints Chief Legal Officer

05.04.24GlobeNewswireNew Board Candidate for the upcoming Annual Geneal Meeting

04.04.24GlobeNewswireNotice convening the Annual General Meeting in BioPorto A/S

04.04.24GlobeNewswireBioPorto Announces Annual Results for 2023

02.04.24GlobeNewswireBioPorto appoints Peter Mørch Eriksen as permanent Group Chief Executive Officer

22.02.24GlobeNewswireBioPorto announces preliminary results for 2023 and provides strategic update for the period 2024-2026

20.02.24GlobeNewswireRoche Diagnostics and BioPorto expand collaboration

09.01.24GlobeNewswireBioPorto implements changes to the Executive Management.

Bioporto A-S News

Bioporto A-S News: auf dieser Seite finden Sie alle Bioporto A-S News und Nachrichten zur Bioporto A-S Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Bioporto A-S News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Bioporto A-S News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.